Key Dates

Related Announcements

• July 29, 2024 - RNA Modifications Driving Oncogenesis (RNAMoDO; U01 Clinical Trial Not Allowed) See NOFO RFA-CA-24-029

Issued by

National Cancer Institute (NCI)

Purpose

The National Cancer Institute (NCI) will hold a pre-application webinar on Tuesday, September 24, 2024, from 3:00–4:00 PM (EDT) for the recently published Notice of Funding Opportunity (NOFO) RFA-CA-24-029 entitled "RNA Modifications Driving Oncogenesis (RNAMoDO; U01 Clinical Trial Not Allowed)".

NCI staff members will provide orientation and programmatic guidance to potential applicants by explaining the goals and objectives of the RNAMoDO program and answering questions from attendees. All potential applicants are encouraged to attend the webinar. The recording of the webinar will be made available on: https://www.cancer.gov/about-nci/organization/dcb/news/past-events. Participation in the webinar meeting, although encouraged, is optional and is not required for the submission of an application in response to the NOFO.

How to Join the Webinar

To join the webinar, pre-registration is required through Zoom (Webinar link will be provided upon registration)

Potential applicants should peruse the NOFO prior to attending the webinar.

Webinar Date: September 24, 2024

Time: 3:00-4:00 pm EDT

Inquiries

Please direct all inquiries to:

Stefan Maas, Ph.D.
National Cancer Institute (NCI)
Email: stefan.maas@nih.gov